Family history and the risk of cancer: genetic factors influencing multiple cancer sites

Expert Review of Anticancer Therapy

Volumn 14, Issue 1, 2014, Pages 1-4

  Turati, Federica ^a   Negri, Eva ^a   Vecchia, Carlo La ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

cancer risk; family history; genetic epidemiology; inheritance; susceptibility

Indexed keywords

CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CASE CONTROL STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FAMILY HISTORY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; REVIEW; RISK FACTOR;

ENVIRONMENTAL EXPOSURE; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NEOPLASMS; RISK FACTORS;

EID: 84893060619     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.2014.863713     Document Type: Review

References (40)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. Lancet 358(9291), 1389-1399 (2001
2. Turati F, Edefonti V, Talamini R et al. Family history of liver cancer and hepatocellular carcinoma. Hepatology 55(5), 1416-1425 (2012
3. Butterworth AS, Higgins JP, Pharoah P. Relative and absolute risk of colorectal cancer for individuals with a family history: A meta-Analysis. Eur. J. Cancer 42(2), 216-227 (2006
4. Clague J, Lin J, Cassidy A et al. Family history and risk of renal cell carcinoma: Results from a case-control study and systematic meta-Analysis. Cancer Epidemiol. Biomarkers Prev. 18(3), 801-807 (2009
5. Lissowska J, Foretova L, Dabek J et al. Family history and lung cancer risk: International multicentre case-control study in Eastern and Central Europe and meta-Analyses. Cancer Causes Control 21(7), 1091-1104 (2010
6. Kicinski M, Vangronsveld J, Nawrot TS. An epidemiological reappraisal of the familial aggregation of prostate cancer: A meta-Analysis. PLoS ONE 6(10), e27130 (2011
7. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA. A systematic review and meta-Analysis of family history and risk of ovarian cancer. Br. J. Obstet. Gynaecol. 105(5), 493-499 (1998
8. Jacobs EJ, Chanock SJ, Fuchs CS et al. Family history of cancer and risk of pancreatic cancer: A pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Int. J. Cancer 127(6), 1421-1428 (2010
9. Negri E, Boffetta P, Berthiller J et al. Family history of cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Int. J. Cancer 124(2), 394-401 (2009
10. Lucenteforte E, Talamini R, Montella M et al. Family history of cancer and the risk of endometrial cancer. Eur. J. Cancer Prev. 18(2), 95-99 (2009
11. Foschi R, Lucenteforte E, Bosetti C et al. Family history of cancer and stomach cancer risk. Int. J. Cancer 123(6), 1429-1432 (2008
12. Li FP, Fraumeni JF Jr. Rhabdomyosarcoma in children: Epidemiologic study and identification of a familial cancer syndrome. J. Natl Cancer Inst. 43(6), 1365-1373 (1969
13. Li FP, Fraumeni JF Jr. Soft-Tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann. Intern. Med. 71(4), 747-752 (1969
14. Malkin D, Li FP, Strong LC et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250(4985), 1233-1238 (1990
15. Poole CA, Byers T, Calle EE, Bondy J, Fain P, Rodriguez C. Influence of a family history of cancer within and across multiple sites on patterns of cancer mortality risk for women. Am. J. Epidemiol. 149(5), 454-462 (1999
16. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF et al. Cancer as a complex phenotype: Pattern of cancer distribution within and beyond the nuclear family. PLoS Med. 1(3), e65 (2004
17. Teerlink CC, Albright FS, Lins L, Cannon-Albright LA. A comprehensive survey of cancer risks in extended families. Genet. Med. 14(1), 107-114 (2012
18. Hemminki K, Sundquist J, Brandt A. Do discordant cancers share familial susceptibility? Eur. J. Cancer 48(8), 1200-1207 (2012
19. Turati F, Edefonti V, Bosetti C et al. Family history of cancer and the risk of cancer: A network of case-control studies. Ann. Oncol. 24(10), 2651-2656 (2013
20. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343(8899), 692-695 (1994
21. The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J. Natl Cancer Inst. 91(15), 1310-1316 (1999
22. Mavaddat N, Peock S, Frost D et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: Results from prospective analysis of EMBRACE. J. Natl Cancer Inst. 105(11), 812-822 (2013
23. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N. Engl. J. Med. 348(10), 919-932 (2003
24. Palmero EI, Achatz MI, Ashton-Prolla P, Olivier M, Hainaut P. Tumor protein 53 mutations and inherited cancer: Beyond Li-Fraumeni syndrome. Curr. Opin. Oncol. 22(1), 64-69 (2010
25. Varley JM. Germline TP53 mutations and Li-Fraumeni syndrome. Hum. Mutat. 21(3), 313-320 (2003
26. Cybulski C, Gorski B, Huzarski T et al. CHEK2 is a multiorgan cancer susceptibility gene. Am. J. Hum. Genet. 75(6), 1131-1135 (2004
27. Taylor AM, Metcalfe JA, Thick J, Mak YF. Leukemia and lymphoma in ataxia telangiectasia. Blood 87(2), 423-438 (1996
28. Thompson D, Duedal S, Kirner J et al. Cancer risks and mortality in heterozygous ATM mutation carriers. J. Natl Cancer Inst. 97(11), 813-822 (2005
29. Bishop DT, Demenais F, Goldstein AM et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J. Natl Cancer Inst. 94(12), 894-903 (2002
30. Shete S, Hosking FJ, Robertson LB et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat. Genet. 41(8), 899-904 (2009
31. Bishop DT, Demenais F, Iles MM et al. Genome-wide association study identifies three loci associated with melanoma risk. Nat. Genet. 41(8), 920-925 (2009
32. Gudbjartsson DF, Sulem P, Stacey SN et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 40(7), 886-891 (2008
33. Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood 101(3), 822-826 (2003
34. Kim WY, Kaelin WG. Role of VHL gene mutation in human cancer. J. Clin. Oncol. 22(24), 4991-5004 (2004
35. Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B. von Hippel-Lindau disease: Genetic, clinical, and imaging features. Radiology 194(3), 629-642 (1995
36. Peto J, Houlston RS. Genetics and the common cancers. Eur. J. Cancer 37(Suppl. 8), S88-S96 (2001
37. Hunter DJ. Gene-environment interactions in human diseases. Nat. Rev. Genet. 6(4), 287-298 (2005
38. Boffetta P, Islami F. The contribution of molecular epidemiology to the identification of human carcinogens: Current status and future perspectives. Ann. Oncol. 24(4), 901-908 (2013
39. Boffetta P, Winn DM, Ioannidis JP et al. Recommendations and proposed guidelines for assessing the cumulative evidence on joint effects of genes and environments on cancer occurrence in humans. Int. J. Epidemiol. 41(3), 686-704 (2012
40. Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ. False-positive results in cancer epidemiology: A plea for epistemological modesty. J. Natl Cancer Inst. 100(14), 988-995 (2008